|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold and securities purchased under resale agreements | ||||||||||||||||||||
| Interest-bearing deposits with banks | ||||||||||||||||||||
| Available-for-sale securities, at fair value | ||||||||||||||||||||
| Held-to-maturity securities, at amortized cost, net of allowance for credit losses of $220, $260 and $398 at June 30, 2026, December 31, 2025 and June 30, 2025, respectively ($2.6 billion, $2.8 billion and $2.9 billion fair value at June 30, 2026, December 31, 2025 and June 30, 2025, respectively) | ||||||||||||||||||||
| Trading account securities | ||||||||||||||||||||
| Equity securities with readily determinable fair value | ||||||||||||||||||||
| Federal Home Loan Bank and Federal Reserve Bank stock | ||||||||||||||||||||
| Brokerage customer receivables | ||||||||||||||||||||
| Mortgage loans held-for-sale, at fair value | ||||||||||||||||||||
| Loans, net of unearned income | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Total loans, net of unearned income | ||||||||||||||||||||
| Allowance for loan losses | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Total allowance for loan losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Premises, software and equipment, net | ||||||||||||||||||||
| Lease investments, net | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Receivable on unsettled securities sales | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other acquisition-related intangible assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated notes | ||||||||||||||||||||
| Junior subordinated debentures | ||||||||||||||||||||
| Payable on unsettled securities sales | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ Equity: | ||||||||||||||||||||
| Preferred stock, no par value; 20,000,000 shares authorized: | ||||||||||||||||||||
| Series D - $25 liquidation value; no shares issued and outstanding at June 30, 2026 and December 31, 2025 and 5,000,000 shares issued and outstanding at June 30, 2025 | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Series F - $25,000 liquidation value; 17,000 shares issued and outstanding at June 30, 2026, December 31, 2025 and June 30, 2025 | ||||||||||||||||||||
| Common stock, no par value; $1.00 stated value; 100,000,000 shares authorized at June 30, 2026, December 31, 2025 and June 30, 2025; 67,581,486 shares issued at June 30, 2026, 67,062,182 shares issued at December 31, 2025 and 67,025,001 shares issued at June 30, 2025 | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Treasury stock, at cost, $126,072 shares at June 30, 2026, and 87,269 shares at December 31, 2025 and June 30, 2025 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
| Treasury stock (in shares) | ||||||||||||||||||||
Loading...
